We have isolated a human cDNA clone encoding a novel protein of 22 kDa that is a human counterpart of the rat oncoprotein PTTG. We show that the corresponding gene (hpttg) is overexpressed in Jurkat cells (a human T lymphoma cell line) and in samples from patients with different kinds of hematopoietic malignancies. Analysis of the sequence showed that hPTTG has an amino-terminal basic domain and a carboxyl-terminal acidic domain, and that it is a proline-rich protein with several putative SH3-binding sites. Subcellular fractionation studies show that, although hPTTG is mainly a cytosolic protein, it is partially localized in the nucleus. In addition we demonstrate that the acidic carboxyl-terminal region of hPTTG acts as a transactivation domain when fused to a heterologous DNA binding domain, both in yeast and in mammalian cells.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1038/sj.onc.1202140 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Tumor Noninvasive and Target Embolization Therapy Platform by Intravenous Injection Based on Acidic Microenvironment-Responsive Hyperbranched Poly(amino acid)s.
ACS Cent Sci
November 2020
Key Laboratory of Eco-Functional Polymer Materials of the Ministry of Education, Key Laboratory of Eco-Environmental Polymer Materials of Gansu Province, College of Chemistry and Chemical Engineering, Northwest Normal University, Lanzhou 730070, China.
Transcatheter arterial embolization (TAE) has been widely applied in treatments of unresectable or hypervascular tumors, but the procedure of TAE is complicated possibly brings inherent risks. Here, inspired by pH-responsive drug delivery systems, a new method of noninvasive and target embolization therapy by intravenous injection was developed. This method is based on a type of acidic microenvironment-responsive hyperbranched poly(amino acid) (HPTTG) to avoid using catheterization and real-time image guidance angiography, simplifying the procedure, elevating compliance and general applicability of embolization therapy.
View Article and Find Full Text PDFCorrelation between narrow-band imaging endoscopy results and hPTTG expression indicated by angiogenensis and its distribution in the initial phase of colorectal adenoma-carcinoma sequence.
Int J Clin Exp Pathol
April 2019
Department of Pathology, Beijing Shijitan Hospital, Capital Medical University Beijing, China.
The aim of the present study was to investigate the correlation between vascular characteristics under narrow band imaging endoscopy (NBI) and the expression of angiogenic factors of colorectal carcinoma and adenoma, and to evaluate the feasibility and validity of NBI in vivo visualizing angiogenesis. Patients with colorectal polyps, which were pathologically confirmed as early carcinoma, adenoma and hyperplastic polyp, were recruited and examined by NBI. The endoscopic vascular pattern was classified by Showa classification.
View Article and Find Full Text PDFProteomics evaluation of MDA-MB-231 breast cancer cells in response to RNAi-induced silencing of hPTTG.
Life Sci
December 2019
Medical Cellular and Molecular Research Center, Golestan University of Medical Sciences, Gorgan, Iran; AryaTinaGene Biopharmaceutical Company, Gorgan, Iran. Electronic address:
Aims: Breast cancer is the most common cancer in women worldwide. Several genes are up-regulated in breast cancer such as human pituitary tumor transforming gene (hPTTG). This study aims to evaluate cell proliferation and the downstream expression pattern of hPTTG1 gene at the mRNA and protein levels after specific down-regulation of hPTTG1 by siRNA.
View Article and Find Full Text PDFRegulation of pituitary tumor transforming gene (PTTG) expression and phosphorylation in thyroid cells.
Endocrinology
November 2013
FRCP, PhD, Senior Clinical Lecturer and Honorary Consultant Physician, Centre for Endocrinology, Diabetes, and Metabolism, School of Clinical and Experimental Medicine, Institute for Biomedical Research, University of Birmingham, Birmingham B15 2TH, United Kingdom.
Article Synopsis
- The human pituitary tumor transforming gene (hPTTG) is a proto-oncogene linked to tumor growth, regulated by cyclin-dependent kinase 2 (CDC2) and specificity protein 1 (SP1).
- *In thyroid cells, growth factors like EGF, TGFα, and IGF-1 boost hPTTG expression and phosphorylation, activating key signaling pathways independently of CDC2 and SP1.
- *Transgenic and knockout mouse models showed that hPTTG influences thyroid cell growth and signaling, suggesting its significant role in promoting cell transformation and growth through autocrine mechanisms.
Histone acetyltransferase p300 regulates the expression of human pituitary tumor transforming gene (hPTTG).
J Genet Genomics
June 2009
Key Laboratory of Molecular Epigenetics of Ministry of Education, Institute of Genetics and Cytology, Northeast Normal University, Changchun, China.
The human pituitary tumor transforming gene (hPTTG) serves as a marker for malignancy grading in several cancers. hPTTG is involved in multiple cellular pathways including cell transformation, apoptosis, DNA repair, genomic instability, mitotic control and angiogenesis induction. However, the molecular mechanisms underlying hPTTG regulation have not been fully explored.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!